Green Bamboo Biotech-B (02480) published the results of the Phase III clinical trial of LZ901 in Nature Communications.

Zhitong Finance APP news, Greentown Bio-B (02480) announced that the results of the Phase III clinical trial of its core product LZ901 conducted in China were published in Nature Communications on August 7, 2026.